This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jean-Michel Le Melledo, MD
St Mary's Hospital McGill University 3830 Lacombe Ave Montreal, Quebec, Canada H3T 1M5

Jacques Bradwejn, MD; Diana Koszycki, PhD
Toronto, Ontario

Daniel Bichet, MD
Montreal

Arch Gen Psychiatry. 1995;52(7):605-606.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We read with interest the article by Leibenluft and colleagues¹ in the October 1994 issue of the ARCHIVES, which summarized the clinical data on how menstrual cycles can influence biochemical responses to biological challenges. Although the review emphasized mood disorder studies, the authors' conclusions can be extended to biological research in panic disorder. An overlooked area in biological studies of panic disorder is the influence of menstrual cycles and premenstrual syndrome on behavioral sensitivity to panicogenic agents. In this regard, we conducted a study to compare the behavioral response of normal women with and without premenstural dysphoric disorder (PDD) to systemic administration of cholecystokinin-tetrapeptide (CCK-4), a well-validated panicogenic agent. We present herein preliminary data collected from 12 women with PDD and 13 women without PDD.

All of our subjects were screened with the Structured Clinical Interview for DSM-III-R, Non-Patient Editor² to exclude those with Axis I disorders. The . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?